Design and Synthesis of Novel Bioactive Peptides and Peptidomimetics

Journal of Medicinal Chemistry

Volumn 46, Issue 26, 2003, Pages 5553-5566

  Freidinger, Roger M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; DIPEPTIDE; DOLASTATIN; DOXORUBICIN; GAMMA LACTAM DERIVATIVE; GLUCAGON; GONADORELIN; GROWTH HORMONE; HEXAPEPTIDE; INSULIN; LACTAM; PENICILLIN G; PEPTIDE; PROSTATE SPECIFIC ANTIGEN; SOMATOSTATIN DERIVATIVE; THIAZINE DERIVATIVE; VINBLASTINE;

CHEMICAL INTERACTION; CONFERENCE PAPER; CYCLIZATION; CYTOTOXICITY; DRUG ACTIVITY; DRUG DESIGN; DRUG SYNTHESIS; MOUSE; NONHUMAN; PROTEIN CONFORMATION;

ANIMALS; ANTINEOPLASTIC AGENTS; DIPEPTIDES; DOXORUBICIN; DRUG DESIGN; HUMANS; LACTAMS; MOLECULAR CONFORMATION; MOLECULAR MIMICRY; PEPTIDES; PEPTIDES, CYCLIC; PROSTATE-SPECIFIC ANTIGEN; SOMATOSTATIN; VINBLASTINE;

EID: 0347626254     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm030484k     Document Type: Conference Paper

References (46)

1. Freidinger, R. M.; Veber, D. F.; Hirschmann, R.; Paege, L. M. Lactam Restriction of Peptide Conformation in Cyclic Hexapeptides Which Alter Rumen Fermentation. Int. J. Pept. Protein Res. 1980, 16, 464-470.
2. Gund, P.; Andose, J. D.; Rhodes, J. B.; Smith, G. M. Three-Dimensional Molecular Modeling and Drug Design. Science 1980, 208, 1425-1431.
3. Fleming, A. On the Antibacterial Action of Cultures of a Penicillium, with Special Reference to Their Use in the Isolation of B. Influenze. Br. J. Exp. Pathol. 1929, 10, 226-236.
4. Hodgkin, D. C. The X-Ray Analysis of the Structure of Penicillin. Adv. Sci. 1949, 6, 85-89.
5. Arai, N.; Shiomi, K.; Yamaguchi, Y.; Masuma, R.; Iwai, Y.; Turberg, A.; Koelbl, H.; Omura, S. Argadin, a New Chitinase Inhibitor, Produced by Clonostachys sp. FO-7314. Chem. Pharm. Bull. 2000, 48, 1442-1446.
6. Houston, D. R.; Shiomi, K.; Arai, N.; Omura, S.; Peter, M. G.; Turberg, A.; Synstad, B.; Eijsink, V. C. H.; van Aalten, D. M. F. High-Resolution Structures of a Chitinase Complexed with Natural Product Cyclopentapeptide Inhibitors: Mimicry of Carbohydrate Substrate. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 9127-9132.
7. Pettit, G. R.; Kamano, Y.; Herald, C. L.; Dufresne, C.; Cerny, R. L.; Herald, D. L.; Schmidt, J. M.; Kizu, H. Antineoplastic Agent. 174. Isolation and Structure of the Cytostatic Depsipeptide Dolastatin 13 from the Sea Hare Dolabella Auricularia. J. Am. Chem. Soc. 1989, 111, 5015-5017.
8. Adamczeski, M.; Quiñoà, E.; Crews, P. Novel Sponge-Derived Amino Acids. 5. Structures, Stereochemistry, and Synthesis of Several New Heterocycles. J. Am. Chem. Soc. 1989, 111, 647-654.
9. (a) Salmeen, A.; Andersen, J. N.; Myers, M. P.; Meng, T.-C.; Hinks, J. A.; Tonks, N. K.; Barford, D. Redox Regulation of Protein Tyrosine Phosphatase IB Involves a Sulphenyl-amide Intermediate. Nature 2003, 423, 769-773.
10. (b) van Montfort, R. L. M.; Congreve, M.; Tisi, D.; Carr, R.; Jhotl, H. Oxidation State of the Active-Site Cysteine in Protein Tyrosine Phosphatase IB. Nature 2003, 423, 773-777.
11. Freidinger, R. M.; Perlow, D. S.; Veber, D. F. Protected Lactam-Bridged Dipeptides for Use as Conformational Constraints in Peptides. J. Org. Chem. 1982, 47, 104-109.
12. Freidinger, R. M. Synthesis of γ-Lactam-Constrained Tryptophyllysine Derivatives. J. Org. Chem. 1985, 50, 3631-3633.
13. Momany, F. A. Conformational Energy Analysis of the Molecule, Luteinizing Hormone-Releasing Hormone. 1. Native Decapeptide. J. Am. Chem. Soc. 1976, 98, 2990-2996.
14. Freidinger, R. M.; Veber, D. F.; Perlow, D. S.; Brooks, J. R.; Saperstein, R. Bioactive Conformation of Luteinizing Hormone-Releasing Hormone: Evidence from a Conformationally Constrained Analog. Science 1980, 210, 656-658.
15. Kopple, K. D. Peptide Backbone Folding in LHRH and Analogs. In Peptides: Synthesis, Structure, Function: Proceedings of the Seventh American Peptide Symposium; Rich, D. H., Gross, E., Eds.; Pierce Chemical Company: Rockford, IL, 1981; pp 295-298.
16. Cascieri, M. A.; Chicchi, G. G.; Freidinger, R. M.; Colton, C. D.; Perlow, D. S.; Williams, B.; Curtis, N. R.; McKnight, A. T.; Maguire, J. J.; Veber, D. F.; Liang, T. Conformationally Constrained Tachykinin Analogs Which Are Selective Ligands for the Eledoisin Binding Site. Mol. Pharmacol. 1986, 29, 34-38.
17. Freidinger, R. M.; Perlow, D. S.; Randall, W. C.; Saperstein, R.; Arison B. H.; Veber D. F. Conformational Modifications of Cyclic Hexapeptide Somatostatin Analogs. Int. J. Pept. Protein Res. 1984, 23, 142-150.
18. (a) Thorsett, E. D.; Harris, E. E.; Aster, S. D.; Peterson, E. R.; Taub, D.; Patchett, A. A. Dipeptide Mimics. Conformationally Restricted Inhibitors of Angiotensin-Converting Enzyme. Biochem. Biophys. Res. Commun. 1983, 111, 166-171.
19. (b) Thorsett, E. D.; Harris, E. E.; Aster, S. D.; Peterson, E. R.; Tristram, E. W.; Snyder, J. P.; Springer, J. P.; Patchett, A. A. Conformationally Restricted Inhibitors of Angiotensin Converting Enzyme. In Peptides, Structure and Function: Proceedings of the Eighth American Peptide Symposium; Pierce Chemical Company: Rockford, IL, 1983; pp 555-558.
20. Wyvratt, M. J.; Tischler, M. H.; Ikeler, T. J.; Springer, J. P.; Tristram, E. W.; Patchett, A. A. Bicyclic Inhibitors of Angiotensin-Converting Enzyme. In Peptides, Structure and Function: Proceedings of the Eighth American Peptide Symposium; Pierce Chemical Company: Rockford, IL, 1983; pp 551-554.
21. Aubé, J. Synthetic Routes to Lactam Peptidomimetics. In Advances in Amino Acid Mimetics and Peptidomimetics; JAI Press Inc.: Greenwich, CT, 1997; Vol. 1, pp 193-232.
22. Halab, L.; Gosselin, F.; Lubell, W. D. Design, Synthesis, and Conformational Analysis of Azacycloalkane Amino Acids as Conformationally Constrained Probes for Mimicry of Peptide Secondary Structures. Biopolymers (Pept. Sci.) 2000, 55, 101-122.
23. Simpson, J. C.; Ho, C.; Shands, E. F. B.; Gershengorn, M. C.; Marshall, G. R.; Moeller, K. D. Conformationally Restricted TRH Analogues: Constraining the Pyroglutamate Region. Bioorg. Med. Chem. 2002, 10, 291-302.
24. Hoffmann, T.; Waibel, R.; Gmeiner, P. A General Approach to Dehydro-Freidinger Lactams: Ex-Chiral Pool Synthesis and Spectroscopic Evaluation as Potential Reverse Turn Inducers. J. Org. Chem. 2003, 68, 62-69.
25. Brazeau, P.; Vale, W.; Burgus, R.; Ling, N.; Butcher, M.; Rivier, J.; Guillemin, R. Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone. Science 1973, 179, 77-79.
26. Veber, D. F.; Holly, F. W.; Paleveda, W. J.; Nutt, R. F.; Bergstrand, S. J.; Torchiana, M.; Glitzer, M. S.; Saperstein, R.; Hirschmann, R. Conformationally Restricted Bicyclic Analogs of Somatostatin. Proc. Natl. Acad. Sci. U.S.A. 1978, 75, 2636-2640.
27. Veber, D. F.; Holly, F. W.; Nutt, R. F.; Bergstrand, S. J.; Brady, S. F. ; Hirschmann, R.; Glitzer, M. S.; Saperstein, R. Highly Active Cyclic and Bicyclic Somatostatin Analogues of Reduced Ring Size. Nature 1979, 280, 512-514.
28. Veber, D. F.; Freidinger, R. M.; Perlow, D. S.; Paleveda, W. J., Jr.; Holly, F. W.; Strachan, R. G.; Nutt, R. F.; Arison, B. H.; Homnick, C.; Randall, W. C.; Glitzer, M. S.; Saperstein, R.; Hirschmann, R. A Potent Cyclic Hexapeptide Analogue of Somatostatin. Nature 1981, 292, 55-58.
29. Veber, D. F.; Saperstein, R.; Nutt, R. F.; Freidinger, R. M.; Brady, S. F.; Curley, P.; Perlow, D. S.; Paleveda, W. J.; Colton, C. D.; Zacchei, A. G.; Tocco, D. J.; Hoff, D. R.; Vandlen, R. L.; Gerich, J. E.; Hall, L.; Mandarino, L.; Cordes, E. H.; Anderson, P. S.; Hirschmann, R. A Super Active Cyclic Hexapeptide Analog of Somatostatin. Life Sci. 1984, 34, 1371-1378.
30. Brady, S. F.; Varga, S. L.; Freidinger, R. M.; Schwenk, D. A.; Mendlowski, M.; Holly, F. W.; Veber, D. F. Practical Synthesis of Cyclic Peptides, with an Example of Dependence of Cyclization Yield upon Linear Sequence. J. Org. Chem. 1979, 44, 3101-3105.
31. Brady, S. F.; Freidinger, R. M.; Paleveda, W. J.; Colton, C. D.; Homnick, C. F.; Whitter, W. L.; Curley, P.; Nutt, R. F.; Veber, D. F. Large-Scale Synthesis of a Cyclic Hexapeptide Analogue of Somatostatin. J. Org. Chem. 1987, 52, 764-769.
32. Freidinger, R. M.; Veber, D. F. Design of Novel Cyclic Hexapeptide Somatostatin Analogs from a Model of the Bioactive Conformation. In Conformationally Directed Drug Design; American Chemical Society: Washington, DC, 1984; pp 169-187.
33. Freidinger, R. M.; Hinkle, J. S.; Perlow, D. S.; Arison, B. H. Synthesis of 9-Fluorenylmethyloxycarbonyl-Protected N-Alkyl Amino Acids by Reduction of Oxazlidinones. J. Org. Chem. 1983, 48, 77-81.
34. Aurelio, L.; Box, J. S.; Brownlee, R. T. C.; Hughes, A. B.; Sleebs, M. M. An Efficient Synthesis of N-Methyl Amino Acids by Way of Intermediate 5-Oxazolidinones. J. Org. Chem. 2003, 68, 2652-2667.
35. Brady, S. F.; Paleveda, W. J., Jr.; Arison, B. H.; Saperstein, R.; Brady, E. J.; Raynor, K.; Reisine, T.; Veber, D. F.; Freidinger, R. M. Approaches to Peptidomimetics Which Serve as Surrogates for the cis Amide Bond: Novel Disulfide-Constrained Bicyclic Hexapeptide Analogs of Somatostatin. Tetrahedron 1993, 49, 3449-3466.
36. Hata, Y.; Matsuura, Y.; Tanaka, N.; Ashida, T.; Kakudo, M. tert-Butyloxycarbonyl-L-cysteinyl-L-cysteine Disulfide Methyl Ester. Acta Crystallogr. 1977, B33, 3561-3564.
37. Goodman, M.; Chorev, M. On the Concept of Linear Modified Retro-peptide Structures. Acc. Chem. Res. 1979, 12, 1-7.
38. Hirschmann, R.; Nicolaou, K. C.; Pietranico, S.; Leahy, E. M.; Salvino, J.; Arison, B.; Cichy, M. A.; Spoors, P. G.; Shakespeare, W. C.; Sprengeler, P. A.; Hamley, P.; Smith, A. B., III; Reisine, T.; Raynor, K.; Maechler, L.; Donaldson, C.; Vale, W.; Freidinger, R. M.; Cascieri, M. R.; Strader, C. D. De Novo Design and Synthesis of Somatostatin Non-Peptide Peptidomimetics Utilzing β-D-Glucose as a Novel Scaffolding. J. Am. Chem. Soc. 1993, 115, 12550-12568.
39. Yang, L.; Berk, S. C.; Rohrer, S. P.; Mosley, R. T.; Guo, L.; Underwood, D. J.; Arison, B. H.; Birzin, E. T.; Hayes, E. C.; Mitra, S. W.; Parmar, R. M.; Cheng, K.; Wu, T.-J.; Butler, B. S.; Foor, F.; Pasternak, A.; Pan, Y.; Silva, M.; Freidinger, R. M.; Smith, R. G.; Chapman, K. Synthesis and Biological Activities of Potent Peptidomimetics Selective for Somatostatin Receptor Subtype 2. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 10836-10841.
40. Hirschmann, R.; Strachan, R. G.; Buchschacher, P.; Sarett, L. H.; Steelman, S. L.; Silber, R. An Approach to an Improved Antliinflammatory Steroid. The Synthesis of 11β, 17-Dihydroxy-3,20-dione-1, 4-pregnadien-21-yl 2-Acetamido-2-deoxy-β-D-glucopyranoside. J. Am. Chem. Soc. 1964, 86, 3903-3904.
41. DeFeo-Jones, D.; Garsky, V. M.; Wong, B. K.; Feng, D.-M.; Bolyar, T.; Kaskell, K.; Kiefer, D. M.; Leander, K.; McAvoy, E.; Lumma, P.; Wai, J.; Senderak, E. T.; Motzel, S. L.; Keenan, K.; Van Zwieten, M.; Lin, J. H.; Freidinger, R.; Huff, J.; Oliff, A.; Jones R. E. A Peptide-Doxorubicin "Prodrug" Activated by Prostate-Specific Antigen Selectively Kills Prostate Tumor Cells Positive for Prostate-Specific Antigen in Vivo. Nat. Med. 2000, 11, 1248-1252.
42. pro) Structure: Basis for Design of Anti-SARS Drugs. Science 2003, 300, 1763-1767.
43. Garsky, V. M.; Lumma, P. K.; Feng, D.-M.; Wai, J.; Ramjit, H. G.; Sardana, M. K.; Oliff, A.; Jones, R. E.; DeFeo-Jones, D.; Freidinger, R. M. The Synthesis of a Prodrug of Doxorubicin Designed To Provide Reduced Systemic Toxicity and Greater Target Efficacy. J. Med. Chem. 2001, 44, 4216-4224.
44. DiPaola, R. S.; Ebbinghaus, S.; Nemunaitis, J.; McCullough, J.; Ciardella, M.; Adams, N.; Williams, A.; Garsky, V.; Wong, B, K.; Defeo-Jones, D.; Jones, R.; Schwartz, M.; Winchell, G.; Arena, C.; Deutsch, P.; Yao, S. Phase I and Pharmacokinetic Study of L377202, a Novel Peptide Doxorubicin Conjugate, in Patients with Advanced Prostate Cancer. Proc. Am. Soc. Clin. Oncol. 2000, 19, 348.
45. Brady, S. F.; Pawluczyk, J. M.; Lumma, P. K.; Feng, D.-M.; Wai, J. M.; Jones, R.; DeFeo-Jones, D.; Wong, B. K.; Miller-Stein, C.; Lin, J. H.; Oliff, A.; Freidinger, R. M.; Garsky, V. M. Design and Synthesis of a Pro-Drug of Vinblastine Targeted at Treatment of Prostate Cancer with Enhanced Efficacy and Reduced Systemic Toxicity. J. Med. Chem. 2002, 45, 4706-4715.
46. DeFeo-Jones, D.; Brady, S. F.; Feng, D.-M.; Wong, B. K.; Bolyar, T.; Haskell, K.; Kiefer, D. M.; Leander, K.; McAvoy, E.; Lumma, P.; Pawluczyk, J. M.; Wai, J.; Motzel, S. L.; Keenan, K.; Van Zwieten, M.; Lin, J. H.; Garsky, V. M.; Freidinger, R.; Oliff, A.; Jones, R. E. A prostate specific antigen (PSA) activated vinblastine prodrug selectively kills PSA secreting cells in vivo. Mol. Cancer Ther. 2002, 1, 451-459.